reslizumab covid | 合法藥品大搜索
由SHanon著作·2020·被引用17次—Inacohortofsevereasthmapatients,asmallnumberofCOVID-19caseswas...inBelgiumareomalizumab,mepolizumab,benralizumabandreslizumab,while ...,由KEger著作·2021·被引用13次—...anddiseasecourseofCOVID-19inpatientswithsevereasthmaonbiologictherapy(omalizumab,mepolizumab,reslizumab,benralizumab, ...,COVID-19:Advice,updatesandvaccineoptions...Reslizumab(IntravenousRoute)...Reslizumabinjectionisusedwithothermedicinesforthemaintenance ...,AStudytoEvaluatetheEfficacyandSafetyo...
reslizumab covid reslizumab covid Donison 副作用 Benzbromarone 結石 baclofen肌肉鬆弛劑 baclofen仿單 Legafen 副作用 安柏寧副作用 baktar禁忌 baktar腎功能
COVID | 合法藥品大搜索
由 S Hanon 著作 · 2020 · 被引用 17 次 — In a cohort of severe asthma patients, a small number of COVID-19 cases was ... in Belgium are omalizumab, mepolizumab, benralizumab and reslizumab, while ... Read More
Poor outcome of SARS | 合法藥品大搜索
由 K Eger 著作 · 2021 · 被引用 13 次 — ... and disease course of COVID-19 in patients with severe asthma on biologic therapy (omalizumab, mepolizumab, reslizumab, benralizumab, ... Read More
Reslizumab (Intravenous Route) Description and Brand ... | 合法藥品大搜索
COVID-19: Advice, updates and vaccine options ... Reslizumab (Intravenous Route) ... Reslizumab injection is used with other medicines for the maintenance ... Read More
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 ... | 合法藥品大搜索
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With ... Read More
Poor outcome of SARS-CoV | 合法藥品大搜索
由 K Eger 著作 · 被引用 13 次 — ... severe course of COVID-19 compared to the general population. ... reslizumab, benralizumab, dupilumab), as compared with COVID-19 data ... Read More
LitCovid - NCBI | 合法藥品大搜索
2021年1月4日 — ... and disease course of COVID-19 in patients with severe asthma on biologic therapy (omalizumab, mepolizumab, reslizumab, benralizumab, ... Read More
Asthma, biologics | 合法藥品大搜索
由 AT Akenroye 著作 · 2020 · 被引用 17 次 — ... of COVID-19 may differ. Omalizumab (an anti–immunoglobulin E [IgE] antibody), mepolizumab and reslizumab (which block interleukin [IL] 5) ... Read More
Anti-IL5 Drugs in COVID-19 Patients | 合法藥品大搜索
由 D Pala 著作 · 2021 — In severe COVID-19 patients, the blockade of eosinophils' activation might ... Anti-IL-5 drugs (benralizumab, mepolizumab, reslizumab) are ... Read More
Eosinophilic Disorders Patients | 合法藥品大搜索
Patients on eosinophil-depleting drugs, such as benralizumab, mepolizumab, and reslizumab, as well as patients on dupilumab, have not been reported to have ... Read More
Reslizumab (Cinqair) | 合法藥品大搜索
Reslizumab (Cinqair). OFFICE ADMININSTRATION. Indications for Prior Authorization: Severe Eosinophilic Asthma. All of the following must be met as a ... Read More
相關資訊整理
【舒肺樂注射劑100毫克/毫升】嚴重氣喘之維持治療：表現型為嗜伊紅性白血球的嚴重氣喘且控制不良(severe refractory eosinophilic asthma)之12歲以上病人之附加維持治療。嗜伊紅性肉芽腫併多發性血管炎：治療嗜伊紅性肉芽腫併多發性血管炎[eosinophilic granulomatosis with polyangiitis (EGPA)]之成人病人。
藥品名稱:舒肺樂注射劑100毫克/毫升許可證字號:衛部菌疫輸字第001144號許可證種類:菌 疫適應症:嚴重氣喘之維持治療：表現型...
【肺昇朗注射液劑30毫克】FASENRA適用於嗜酸性白血球表現型的嚴重氣喘成人病人，做為附加維持治療。
藥品名稱:肺昇朗注射液劑30毫克許可證字號:衛部菌疫輸字第001101號許可證種類:菌 疫適應症:FASENRA適用於嗜酸性白血球表現...